No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Taeniasis is a parasitic infection caused by the tapeworm species Taenia solium. It is a neglected tropical disease, and is most common in developing countries. Treatment of taeniasis is typically done with anthelmintic drugs, which are drugs that kill parasitic worms. These drugs are usually administered orally, and the most commonly used drugs are niclosamide and praziquantel. Niclosamide is the drug of choice for taeniasis, as it is effective and has fewer side effects than praziquantel.
The taeniasis drug market is a small but growing market, as the prevalence of taeniasis is increasing in many parts of the world. The market is expected to grow in the coming years, as more people become aware of the disease and its treatment. The market is also expected to benefit from the development of new drugs and treatments for taeniasis.
Some of the companies in the taeniasis drug market include Merck & Co., Inc., GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., and Bayer AG. Show Less Read more
